To view this email as a web page, click here.

Can A Vaccine Help Reduce Herpes Zoster After ASCT?

Researchers looked at whether or not a two-dose recombinant zoster vaccine would reduce the incidence of herpes zoster in patients with hematologic malignancies after autologous stem cell transplantation.

Cell of Origin, MYC/BCL2 Status Did Not Predict Outcomes in Early-Stage DLBCL

Cell of origin and dual expressor/double-hit status may not confer prognosis as originally suspected.

IN CASE YOU MISSED IT

Is MRI or Mammography the Better Approach to Breast Cancer Screening?

The FaMRIsc trial was designed to compare MRI and mammography screening in women with familial risk but no known specific driver mutation.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.